Login Register
icon_bulk_orderBulk order Acrobiosystems for English
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IL-7 R alpha

IL-7 R alpha

Brief Information

Name:Interleukin-7 receptor subunit alpha
Target Synonym:IL-7R-Alpha,Interleukin 7 Receptor Isoform H5-6,Interleukin 7 Receptor Alpha Chain,CD127,IL7RA,ILRA,Interleukin-7 Receptor alpha Subunit,Interleukin-7 receptor subunit alpha,CDw127,IL-7RA,IL-7 receptor subunit alpha,IL7R,Interleukin 7 Receptor,CD127 Antigen,IL-7R subunit alpha
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:6
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Part of Bioactivity data


Captured Human IL-7 R alpha, Mouse IgG2a Fc Tag (Cat. No. IL7-H5258) on CM5 chip via anti-mouse antibodies surface can bind ActiveMax® Human IL-7, Tag Free (Cat. No. IL7-H4219) with an affinity constant of 13.3 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

Biotinylated Human IL-7 R alpha, Fc,AvitagBiotinylated Human IL-7 R alpha, Fc,Avitag (Cat. No. IL7-H82F8) ELISA bioactivity

Immobilized ActiveMax® Human IL-7, Tag Free (Cat. No. IL7-H4219) at 10 μg/mL (100 μL/well) can bind Biotinylated Human IL-7 R alpha, Fc,Avitag (Cat. No. IL7-H82F8) with a linear range of 139 ng/mL (QC tested).

Synonym Name



Interleukin-7 receptor subunit alpha (IL7Ra) is also known as CD antigen CD127, which belongs to the type I cytokine receptor family and type 4 subfamily. IL7Ra /CD127 contains 1 fibronectin type-III domain. IL7Ra /CD127 is expressed on various cell types, including naive and memory T cells and many others. IL7Ra /CD127 is receptor for interleukin-7 and also acts as a receptor for thymic stromal lymphopoietin (TSLP). The IL7 receptor is a heterodimer of IL7R and IL2RG. The TSLP receptor is a heterodimer of CRLF2 and IL7R.

Clinical and Translational Updates

Related Molecule

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Interleukin-7 (Revimmune SAS) rhIL-7; CYT-107; CYT-99-007 Phase 2 Clinical Cytheris Mycobacterium Infections, Nontuberculous; Melanoma; Leukemia, Myeloid, Acute; Colorectal Neoplasms; Hepatitis C; Lymphopenia; Prostatic Neoplasms; Breast Neoplasms; Urinary Bladder Neoplasms; HIV Infections; Sepsis; Myeloproliferative Disorders; Coronavirus Disease 2019 (COVID-19); Hepatitis B, Chronic; Shock, Septic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Kidney Neoplasms Details
GSK-2618960 GSK-2618960 Phase 2 Clinical Glaxosmithkline Plc Multiple Sclerosis, Relapsing-Remitting; Autoimmune Diseases; Sjogren's Syndrome Details
BNT-152 BNT-152 Phase 1 Clinical Biontech Se Solid tumours Details
Lusvertikimab OSE-127; S-95011 Phase 2 Clinical Effimune Sjogren's Syndrome; Colitis, Ulcerative; Inflammation Details
ASP-9801 ASP-9801 Phase 1 Clinical Astellas Pharma Inc Solid tumours; Neoplasm Metastasis Details
Efineptakin alfa (Genexine/NeoImmuneTech) GX-I7; TJ-107; NT-I7 Phase 2 Clinical Genexine Inc Coronavirus Disease 2019 (COVID-19); Melanoma; Carcinoma, Non-Small-Cell Lung; Glioma; Carcinoma, Squamous Cell; Cervical Intraepithelial Neoplasia; Colorectal Neoplasms; Brain Neoplasms; Papillomavirus Infections; Ovarian Neoplasms; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Glioblastoma; Triple Negative Breast Neoplasms; Carcinoma, Merkel Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Solid tumours Details

This web search service is supported by Google Inc.

Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message